Saturday, May 18, 2013 Last update: 9:34 AM
Company Tech News as it Breaks

Integrated BioTherapeutics Inc

News articles for Integrated BioTherapeutics Inc:

Tuesday, February 26, 2013

  • New Bioterrorism Vaccine Gets First Test In Humans
    GAITHERSBURG, Md., Feb. 26, 2013 /PRNewswire/ -- Integrated BioTherapeutics (IBT) announces the initiation of a Phase 1 clinical trial testing the safety and immunogenicity of its staphylococcal enterotoxin B vaccine "STEBVAX" in healthy adults. This trial, marking the first time a superantigen vaccine has been administered ... read more